Platelet CD62 expression and PDGF(AB) secretion in patients undergoing PTCA and treatment with abciximab

Lignende værker

• Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects
  af: Klinkhardt, Ute, et al.
  Udgivet: (2001)
• Platelet-derived growth factor (PDGF)-AB-mediated phosphorylation of PDGF beta receptors.
  af: Coats, S R, et al.
  Udgivet: (1994)
• Pharmacodynamic characterization of the interaction between the glycoprotein IIb/IIIa inhibitor YM337 and unfractionated heparin and aspirin in humans
  af: Graff, Jochen, et al.
  Udgivet: (2003)
• The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors.
  af: Raines, E W, et al.
  Udgivet: (1992)
• Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: a randomised trial
  af: van Werkum, J.W., et al.
  Udgivet: (2007)